These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 17671721
1. Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease. You XJ, Bryant PJ, Jurnak F, Holcombe RF. Oncol Rep; 2007 Sep; 18(3):691-4. PubMed ID: 17671721 [Abstract] [Full Text] [Related]
2. Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma. Milovanovic T, Planutis K, Nguyen A, Marsh JL, Lin F, Hope C, Holcombe RF. Int J Oncol; 2004 Nov; 25(5):1337-42. PubMed ID: 15492823 [Abstract] [Full Text] [Related]
3. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T. Mol Pathol; 2002 Aug; 55(4):220-6. PubMed ID: 12147710 [Abstract] [Full Text] [Related]
5. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H. J Gastroenterol; 2003 Aug; 38(3):229-37. PubMed ID: 12673445 [Abstract] [Full Text] [Related]
6. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6. Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A, Mantovani A, Locati M, Danese S. Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409 [Abstract] [Full Text] [Related]
8. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry. ter Beek WP, Biemond I, Muller ES, van den Berg M, Lamers CB. Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742 [Abstract] [Full Text] [Related]
10. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Chen LC, Hao CY, Chiu YS, Wong P, Melnick JS, Brotman M, Moretto J, Mendes F, Smith AP, Bennington JL, Moore D, Lee NM. Cancer Res; 2004 May 15; 64(10):3694-700. PubMed ID: 15150130 [Abstract] [Full Text] [Related]
11. WNT/PCP signaling pathway and human cancer (review). Katoh M. Oncol Rep; 2005 Dec 15; 14(6):1583-8. PubMed ID: 16273260 [Abstract] [Full Text] [Related]
12. Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: a comparative study of inflammatory bowel disease and colonic neoplasms. Vainer B, Horn T, Nielsen OH. Scand J Gastroenterol; 2006 Mar 15; 41(3):318-25. PubMed ID: 16497620 [Abstract] [Full Text] [Related]
13. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A. Anticancer Res; 2008 Mar 15; 28(5A):2613-23. PubMed ID: 19035286 [Abstract] [Full Text] [Related]
14. Invasive colon cancer, but not non-invasive adenomas induce a gradient effect of Wnt pathway receptor frizzled 1 (Fz1) expression in the tumor microenvironment. Planutis K, Planutiene M, Nguyen AV, Moyer MP, Holcombe RF. J Transl Med; 2013 Feb 26; 11():50. PubMed ID: 23442549 [Abstract] [Full Text] [Related]
15. Non-conventional Frizzled ligands and Wnt receptors. Hendrickx M, Leyns L. Dev Growth Differ; 2008 May 26; 50(4):229-43. PubMed ID: 18366384 [Abstract] [Full Text] [Related]
16. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. J Clin Oncol; 2007 Sep 20; 25(27):4231-8. PubMed ID: 17878476 [Abstract] [Full Text] [Related]
17. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Rubio CA, Befrits R, Jaramillo E, Nesi G, Amorosi A. Anticancer Res; 2000 Sep 20; 20(6C):4761-4. PubMed ID: 11205214 [Abstract] [Full Text] [Related]
18. Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease. Dandrieux JR, Bornand VF, Doherr MG, Kano R, Zurbriggen A, Burgener IA. Am J Vet Res; 2008 Oct 20; 69(10):1279-85. PubMed ID: 18828683 [Abstract] [Full Text] [Related]
19. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease. Farhadi A, Keshavarzian A, Fields JZ, Jakate S, Shaikh M, Banan A. J Gastroenterol Hepatol; 2007 Dec 20; 22(12):2338-43. PubMed ID: 17645464 [Abstract] [Full Text] [Related]
20. Low prevalence of the APC I1307K sequence in Jewish and non-Jewish patients with inflammatory bowel disease. Yin J, Harpaz N, Souza RF, Zou T, Kong D, Wang S, Leytin AL, Medalie NS, Smolinski KN, Abraham JM, Fleisher AS, Meltzer SJ. Oncogene; 1999 Jul 01; 18(26):3902-4. PubMed ID: 10445854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]